North America dPCR and qPCR Market Forecast to 2030
North America dPCR and qPCR Market Forecast to 2030 – Regional Analysis – By Treatment [Quantitative PCR (qPCR) and Digital PCR (dPCR)], Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), and End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Incidence of Genetic and Infectious Diseases Drive North America dPCR and qPCR Market
According to the National Organization’s information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. In 2022, a report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year, accounting for ? 5% of the global population. In the US, it is one of the most prevalent genetic conditions. Also, 1 in 500 African Americans is affected by sickle cell disease, and ? 1 in 12 of them suffers from the autosomal recessive mutation, according to the CDC. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These product include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium-, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space.
Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the North America dPCR and qPCR market.
North America dPCR and qPCR Market Overview
The North America dPCR and qPCR market in North America is segmented into the US, Canada, and Mexico. North America is the largest market for biotechnology, with the US holding the largest market share, followed by Canada. The market growth in North America is attributed to an increase in the demand for innovative products from bio-analytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. The increasing focus on advanced method incorporation in healthcare, government and private initiatives for promoting precision medicine, and massive funds from government and private bodies for genomic research are also expected to stimulate the growth and contribute to exceptional revenue generation for the North America dPCR and qPCR market in North America. Additionally, scientific advances made by various research groups in the country correspond to the growth and dominance of the region in the global market positioning.
North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)
North America dPCR and qPCR Market Segmentation
The North America dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.
Based on treatment, the North America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.
By product, the North America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.
By application, the North America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.
By end user, the North America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.
Based on country, the North America dPCR and qPCR market is segmented into segmented into the US, Canada, and Mexico. The US dominated the North America dPCR and qPCR market in 2022.
Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the North America dPCR and qPCR market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the North America dPCR and qPCR market was valued at US$ 3,551.08 million in 2022 and is expected to reach US$ 7,429.03 million by 2030, registering a CAGR of 9.7% from 2022 to 2030. Rising investments and funds for gene synthesis and increasing incidence of genetic and infectious diseases are among the critical factors attributed to the North America dPCR and qPCR market expansion.
Gene synthesis is the most accepted tool in the fields of recombinant DNA technology, which includes recombinant protein production and PCR technology for amplification as well as quantification purposes. In 2021, The synthetic biology startup Camena Bioscience, which supplies genes to the biotechnology and pharmaceutical sectors, completed a US$10 million Series A funding round headed by Mercia. With the additional funds, the company will expand operations and keep developing gSynth, its ground-breaking DNA synthesis platform. The technology platform and other related resources help the company to accelerate the development of gene synthesis. Companies have also increased their research and development funds for the enhancement of gene synthesis.
In 2020, EVONETIX LTD, a synthetic biology startup creating a desktop platform for high-fidelity, rapid, and scalable gene synthesis, announced the completion of its Series B financing round. The company, led by new investor Foresite Capital, raised US$ 30 million (£23 million) in this round. Investors such as Draper Esprit, DCVC (Data Collective), the Morningside group, Providence Investment Company, and Cambridge Consultants Ltd also participated in the round, Rising Tide Fund, and Civilization Ventures. Thus, rising investments made by government companies fuel the global gene synthesis market growth.
On the contrary, high costs of PCR systems hampers the growth of North America dPCR and qPCR market.
Based on treatment, the North America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held 73.5% share of the North America dPCR and qPCR market in 2022, amassing US$ 2,611.41 million. It is projected to garner US$ 5,708.28 million by 2030 to expand at 10.3% CAGR during 2022–2030.
By product, the North America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 58.2% share of the North America dPCR and qPCR market in 2022, amassing US$ 2,067.70 million. It is projected to garner US$ 4,635.35 million by 2030 to expand at 10.6% CAGR during 2022–2030.
By application, the North America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held 57.3% share of the North America dPCR and qPCR market in 2022, amassing US 2,033.10 million. It is projected to garner US$ 4,716.82 million by 2030 to expand at 11.1% CAGR during 2022–2030. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.
By end user, the North America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held 57.3% share of the North America dPCR and qPCR market in 2022, amassing US$ 2,033.10 million. It is projected to garner US$ 4,716.82 million by 2030 to expand at 11.1% CAGR during 2022–2030.
Based on country, the North America dPCR and qPCR market is segmented into segmented into US, Canada, and Mexico. The US held 83.8% share of North America dPCR and qPCR market in 2022, amassing US$ 2,975.20 million. It is projected to garner US$ 6,400.87 million by 2030 to expand at 10.1% CAGR during 2022–2030.
Key players operating in the North America dPCR and qPCR market are Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in North America dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the dPCR and qPCR market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America dPCR and qPCR Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Incidence of Genetic and Infectious Diseases
4.1.2 Rising Investments and Funds for Gene Synthesis
4.1.3 Technological Advancements in PCR Technologies
4.2 Market Restraints
4.2.1 High Costs of PCR Systems
4.2.2 Technical Limitations Associated with qPCR
4.3 Market Opportunities
4.3.1 Growing Adoption of PCR Methods in Emerging Countries
4.4 Future Trends
4.4.1 Development of Droplet Digital PCR
4.5 Impact Analysis:
5. dPCR and qPCR Market – North America Market Analysis
5.1 North America dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
6. North America dPCR and qPCR Market – Revenue and Forecast to 2030 – by Treatment
6.1 Overview
6.2 North America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
6.3 Quantitative PCR
6.3.1 Overview
6.3.2 Quantitative PCR: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Digital PCR
6.4.1 Overview
6.4.2 Digital PCR: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7. North America dPCR and qPCR Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 North America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
7.3 Reagents & Consumables
7.3.1 Overview
7.3.2 Reagents & Consumables: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8. North America dPCR and qPCR Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 North America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
8.3 Research Application
8.3.1 Overview
8.3.2 Research Application: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Application
8.4.1 Overview
8.4.2 Clinical Application: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 North America dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
8.5 Forensic Application
8.5.1 Overview
8.5.2 Forensic Application: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9. North America dPCR and qPCR Market – Revenue and Forecast to 2030 – by End-User
9.1 Overview
9.2 North America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Research Laboratories and Academic Institutes
9.5.1 Overview
9.5.2 Research Laboratories and Academic Institutes: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Forensic Laboratories
9.6.1 Overview
9.6.2 Forensic Laboratories: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Clinical Research Organizations
9.7.1 Overview
9.7.2 Clinical Research Organizations: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10. North America dPCR and qPCR Market – Country Analysis
10.1.1 North America dPCR and qPCR Market, by Country
10.1.1.1 US
10.1.1.1.1 US : North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 US: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.1.3 US: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.4 US: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4.1 US: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.1.5 US: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
10.1.1.2 Canada
10.1.1.2.1 Canada: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Canada: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.2.3 Canada: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 Canada: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4.1 Canada: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.2.5 Canada: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
10.1.1.3 Mexico
10.1.1.3.1 Mexico: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 Mexico: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.3.3 Mexico: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 Mexico: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4.1 Mexico: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.3.5 Mexico: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11. dPCR and qPCR Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in North America dPCR and qPCR Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Takara Bio Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Qiagen NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Standard BioTools Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Lepu Medical Technology Beijing Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 F. Hoffmann-La Roche Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bio-Rad Laboratories Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Agilent Technologies Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America dPCR and qPCR Market Segmentation
Table 2. North America dPCR and qPCR Market, by Clinical Application – Revenue and Forecast to 2030 (US$ Million)
Table 3. US: North America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. US: North America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. US: North America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada: North America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada: North America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada: North America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada: North America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: North America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico: North America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico: North America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico: North America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico: North America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Organic Growth Strategies in North America dPCR and qPCR Market
Table 19. Recent Inorganic Growth Strategies in the North America dPCR and qPCR Market
Table 20. Glossary of Terms, North America dPCR and qPCR Market
LIST OF FIGURES
Figure 1. North America dPCR and qPCR Market Segmentation, By Country
Figure 2. North America dPCR and qPCR Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
Figure 5. North America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 6. Quantitative PCR: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Digital PCR: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. North America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 9. Reagents & Consumables: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Instruments: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Software & Services: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 13. Research Application: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Clinical Application: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Forensic Application: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 17. Hospitals and Diagnostic Centers: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Pharmaceutical and Biotechnology Companies: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Research Laboratories and Academic Institutes: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Forensic Laboratories: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Clinical Research Organizations: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. North America: North America dPCR and qPCR Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 24. US : North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Canada: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Mexico: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Growth Strategies in North America dPCR and qPCR Market
The List of Companies – North America dPCR and qPCR Market
1. Abbott Laboratories
2. Thermo Fisher Scientific Inc
3. Takara Bio Inc
4. Qiagen NV
5. Standard BioTools Inc
6. Lepu Medical Technology Beijing Co Ltd
7. F. Hoffmann-La Roche Ltd
8. Bio-Rad Laboratories Inc
9. Agilent Technologies Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.